A. Introduction
Colony-stimulating factors (CSFs) are a family of hematopoietic growth factors required for the proliferation and differentiation of hematopoietic progenitor cells [I, 2] . In the human system, purification to homogeneity and biochemical characterization has only been reported for macrophage-active CSF (CSF-l) [3] . However, there are many reports about highly purified human granulocyte-macrophage CSFs (e.g. [4] [5] [6] [7] ), but not about pluripotent human CSF.
Assays are available to detect human clonogenic precursors that give rise to cells of the erythroid, granulocytic, megakaryocytic, macrophage, colony-forming unit granulocytes, erythrocytes, macrophages, and megakaryocytes, CFU-GEMM, and possibly lymphoid lineages [8] [9] [10] . CSFs with activities on these pluripotential progenitor cells (pluripotent CSF) are produced by mitogen-or antigen-activated T-lymphocytes [11] and by human tumorcell lines [12] or HTLV-transformed lymphoid cells [13] .
We report in this paper the purification to homogeneity and biochemical charac- 
B. Assay Systems
Granulocyte-macrophage-CSF (G M -CSF), granulocyte-macrophage-erythrocyte-megakaryocyte-CSF (GEMM-CSF), and early erythroid burst-forming unit (BFU-E) activities were tested on low-density, T-celldepleted, nonadherent human bone marrow cells as described [14] [15] and detailed in another paper by Platzer et al. in this volume. For assay of differentiation induction, the method of Metcalf [16] was used, whereby pluripotent CSF was added to cultures of the murine myelomonocytic WEHI-3B (D +) or the human promyelocytic HL-60 leukemic cells and scored for differentiation on day 7 and 14 respectively.
As shown in the Results, a single protein stimulates colony formation by CFU-GEMM, BFU-E, and CFU-GM progenitor cells. We termed this protein "pluripotent CSF" or "pluripoietin". Due to the low numbers of mixed colonies per dish attainable in this assay system, titration of test samples for determination of pluripotent CSF activity presented difficulties in quantitation. Therefore, we used the GM-CSF assay as described [14, 15] to measure the GM-CSF aspect of the pluripotent CSF in the samples that supported growth ofCFU-GEMM and BFU-E for calculating the specific activities throughout the purification procedure. a Units of activity in the GM-CSF assay in agar, as tested on low-density normal human bone marrow cells b Estimate of -fold purification based on starting activity from one selected peak of DE 52 C. Purification of Pluripotent CSF The human bladder carcinoma-cell line 5637 has been reported to produce constitutively a GM-CSF [17] and GEMM-CSF [12] . The cells were cultured in RPMI 1640 supplemented with glutamine (2 mM), antibiotics, and 10% fetal calf serum (FCS). For production of pluripotent CSF used for purification cells were kept for 48-72 h in medium containing low serum (0.2% FCS). The conditioned medium from low-serum-containing cultures was harvested and used for purification. The first three steps of purification involved ammonium sulfate precipitation (80% saturation), anion-exchange chromatography [diethylaminoethanol (DEAE)-cellulose, DE 52, Whatman, Clifton, NJ], and gel filtration (AcA 54 Ultrogel, LKB Products, Inc., Rockland, MD) ( Table 1) . These steps were used because they were highly effective for other cytokines, notably Interleukin 2 [18] and B-cell-differentiating factor [19] and have been described in detail elsewhere [18] . Pluripotent CSF eluted from the DE 52 cellulose column between 0.075 and 0.1 M NaCI in 0.05 M Tris/HCI, pH 7.8, and from the AcA 54 column with a single peak at around 32 000 molecular weight. The final step involved chromatography on a reverse-phase high-performance liquid chromatography (HPLC) column (uBondapak C 18, Waters) and a Waters HPLC system using I-propanol as organic solvent (20%-50% I-propanol gradient in 2 h) and a buffer system containing 0.9 M acetic acid and 0.2 M pyridine, pH 4.0. Pluripotent CSF activity eluted as a single peak at 42% I-propanol. The purification schedule with degree of purification of pluripotent CSF as measured by GM-CSF activity, protein content, specific activity, and yield is detailed in Table 1 . We obtained a specific activity of 1.5 X 10 8 U / mg protein.
D. Biochemical Characterization of Pluripotent CSF
The final preparation obtained after HPLC was analyzed on a 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel [20] followed by the sensitive silver staining technique (Biorad Lab., Rockville Centre, NY; Fig. 1 ). Only one protein band with a molecular weight of 18000 was seen under reducing (5% 2-mercaptoethanol; Fig. 1 ) and nonreducing (not shown) conditions. After electrophoresis under nonreducing conditions, a parallel gel was sliced into 2-mm sections and proteins eluted from each slice into phosphate buffer. Pluripotent CSF was found to be localized in the slice number corresponding to 18 000 molecular weight (Fig. 1) . Reelectrophoresis of the protein in the active slice-fraction with SDS-PAGE under reducing conditions revealed again a protein band of 18 000 molecular weight (not shown).
The purified pluripotent CSF was also subjected to isoelectrofocusing analysis in f t t t 25.7 181 .4 14,3 12.3 X 'O~ ~ ~ ~ + Fig. 1 . SDS-PAGE. The pluripotent CSF eluted from the HPLC column (peak fraction) was lyophilized and treated with 1% SDS in 0.065 M Tris/HCI, pH 6.8, and 20% glycerol, under reducing conditions (5% 2-mercaptoethanol) for 1 h at 37°C and then applied to a 15% polyacrylamide gel [20] . After electrophoresis, the proteins were visualized by the silver staining technique (upper panel). Treatment of pluripotent CSF under nonreducing conditions and subsequent electrophoresis gave the same results. For elution of biological activity pluripotent CSF was treated as above (nonreducing conditions) and after electrophoresis under the same conditions the gel was sliced into 2-mm sections and proteins from each slice were eluted into phosphate buffer (20 mM, pH 7.2). After 18 h eluted proteins were assayed for pluripotent activity (lower panel; GM-CSF activity, black columns). The following marker proteins (arrows) were used: ovalbumin (molecular weight, 43 000), chymotrypsinogen (molecular weight, 25 700), lactoglobulin (molecular weight, 18400), lysozyme (molecular weight, 14300), and cytochrome C (molecular weight, 12300) No an IEF column (LKB 8100) [18] using ampholines with a pH range of 3.5-10. Pluripotent CSF was localized in one fraction with a pH of 5.5 ( Table 2 ).
E. Biological Activity of Pluripotent CSF Fifty units of GM-CSF activity of pluripotent CSF (1.8 X 10-11 M) supported the half-maximal cloning of CFV-GM, while 500 Vlml was needed to support the cloning of human CFV-GEMM and BFV-E. In addition pluripotent CSF at a concentration of between 500 and 1000 Vlml was capable of inducing differentiation of the leukemic cell lines HL-60 and WEHI-3B (D +). A detailed biological characterization of pluripotent CSF is described in the paper by Platzer et al. in this volume.
F. Discussion
The protein described in this paper is capable of stimulating the in vitro growth of human mixed colony progenitor cells (CFV-GEMM), early erythroid progenitor cells (BFV-E), and granulocyte-macrophage progenitors (CFU-GM) and in addition induces differentiation of the murine myelomonocytic (WEHI-3B (D + )) and the human promyelocytic (HL-60) leukemic cell lines. It has a molecular weight of 18000 and an isoelectric point of 5.5. The specific activity is 1.5 X 10 8 Vlmg protein.
The purified protein, shown in Fig. I , and the pluripotent CSF activity are identical because: (1) protein and activity eluted in the same fraction from the HPLC; (2) we were not able to separate biological activity and the 18000 molecular weight protein by using additional HPLC columns (Diphenyl, C4, Hydroxylapatite) and buffer systems; (3) identical localization of protein and activity in SDS-PAGE (Fig. 1) ; (4) high specific activity (1.5 X 10 8 Vlmg protein; I V = 3.7 X 10-13 M), which is comparable to pure murine CSF [21] and human CSF-l [3] . Therefore, it is very unlikely that pluripotent CSF activity is not associated with the 18000 molecular weight protein.
The availability of purified human pluripotent CSF has important and farreaching implications for the analysis of human hematopoiesis and possibly for the understanding and management of clinical diseases involving hematopoietic derangement or failure.
